Genomics England, a company wholly owned and funded by the Department of Health & Social Care, was set up to deliver this flagship project which will sequence 100,000 whole genomes from NHS patients. Its four main aims are; to create an ethical and transparent programme based on consent; to bring benefit to patients and set up a genomic medicine service for the NHS; to enable new scientific discovery and medical insights; and to kick start the development of a UK genomics industry.

This project is an important and exciting research area:

The Cure Parkinson’s Trust is a keen supporter of the 100,000 genome project. More and more we are seeing how the combining of genomic sequence data with medical records is proving to be a ground-breaking resource.  Genomics has already started to guide and inform doctors about the best treatment for individual patients. If we can forecast how well a person will respond to a treatment or determine what will work best for them – so called personalised medicine – this will be of huge benefit to people living with Parkinsons now and in the future.

The 100,000 Genomes Project only remains open until 30th September. If you have early onset Parkinson’s or atypical Parkinson's (onset 45 years of age or under or history of Parkinson’s Disease in your family), are based in the UK and would like to contribute your genetic data to this pivotal government funded study, please email Helen and we will direct you to the investigators who can provide postal consent forms. Participation involves providing a blood sample via your GP or local consultant.

Find out more about this study here: